European Journal of Cancer, 186, 27-37. Elsevier Ltd. European Journal of Cancer, 186, 27-37 van Not, O J, van den Eertwegh, A J M, Haanen, J B, van Rijn, R S, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Boers-Sonderen, M J, van Eijs, M J M, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, de Meza, M, Piersma, D, Stevense-den Boer, M, van der Veldt, A A M, Vreugdenhil, G, Wouters, M W J M, Suijkerbuijk, K P M & Blokx, W A M 2023, ' Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies ', European Journal of Cancer, vol. 186, pp. 27-37 . https://doi.org/10.1016/j.ejca.2023.03.009 European Journal of Cancer, 186, 27-37. Pergamon European Journal of Cancer, 186, 27-37. ELSEVIER SCI LTD European Journal of Cancer, 186, pp. 27-37
Melanoma Research, 32, 6, pp. 460-468 Melanoma Research, 32(6), 460-468. Lippincott Williams & Wilkins Melanoma Research, 32(6), 460-468. Lippincott Williams and Wilkins Melanoma Research, 32(6), 460-468. LIPPINCOTT WILLIAMS & WILKINS Melanoma Research, 32(6), 460. Lippincott Williams and Wilkins Melanoma Research, 32, 460-468 Ismail, R K, Suijkerbuijk, K P M, de Boer, A, van Dartel, M, Hilarius, D L, Pasmooij, A M G, van Zeijl, M C T, Aarts, M J B, van den Berkmortel, F W P J, Blank, C U, Boers-Sonderen, M J, de Groot, J W B, Haanen, J B A G, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, van der Veldt, A A M, Vreugdenhil, A, Westgeest, H, van den Eertwegh, A J & Wouters, M W J M 2022, ' Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors ', Melanoma Research, vol. 32, no. 6, pp. 460-468 . https://doi.org/10.1097/CMR.0000000000000832